Mein Warenkorb

HLA-E*0103 & B2M & CMV UL40 (VMAPRTVLL)

HLA-E*0103 & B2M & CMV UL40 (VMAPRTVLL) Produktliste

  • Attribut

    Protein (3)

  • Produktbibliothek

    Online (3)

  • Spezies

    Human (3)

  • Etikett

    His Tag & Avi Tag (2)His Tag (1)

  • Marker

    Biotin-labeled (1)PE Labeled (1)Unconjugated (1)

HLA-E*0103 & B2M & CMV UL40 (VMAPRTVLL) Molekülhintergrund

HLA-E belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. HLA-E binds a restricted subset of peptides derived from the leader peptides of other class I molecules. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Human prothrombin complex concentrate (Sichuan Yuanda Shuyang Pharmaceutical)Phase 3 ClinicalBlood Coagulation Disorders
Details
Human prothrombin complex concentrate (Harbin Shiheng Bioengineering Pharmaceutical)Phase 3 ClinicalHarbin Pacific Biopharmaceutical Co LtdHemophilia B
Details
Human prothrombin complex (Lanzhou Lansheng Blood Products)Phase 3 ClinicalLanzhou Lansheng Blood Products Co LtdHemophilia B
Details
Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical)Phase 3 ClinicalHunan Ziguang Huhan Nanyue Pharmaceutical Co LtdHemophilia B
Details
Factor VII (KM Biologics)KD2-305Phase 3 ClinicalHemophilia A
Details
HMB-001HMB001Phase 2 ClinicalHemab Therapeutics APSThrombasthenia
Details
Human prothrombin complex (National Drug Group Wuhan Blood)Phase 1 ClinicalHemorrhage
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Anti-inhibitor coagulant complex (Baxalta)ApprovedBaxalta IncorporatedFeiba, Prothromplex TOTALUnited StatesHemophilia A; Hemophilia BBaxalta Incorporated1979-12-21Blood Coagulation Disorders; Blood Coagulation Disorders, Inherited; Hemophilia A; Hemophilia B; Cardiovascular Diseases
Details
Human prothrombin complex (Nanyue Biopharming)ApprovedHunan Ziguang Huhan Nanyue Pharmaceutical Co LtdMainland ChinaHemorrhageHunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd2019-09-05Hemophilia B; Hemorrhage
Details
Human prothrombin complex (CSL Behring)BE-1116ApprovedCsl Behring LlcKcentra, Beriplex, ConfidexBlood Coagulation Disorders; Coagulation Protein Disorders; Heart Failure; Heart Diseases; Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Wounds and Injuries
Details
Human prothrombin complex concentrate (Guizhou Taibang Biological Products)ApprovedGuizhou Taibang Biological Products Co LtdMainland ChinaHypoprothrombinemiasGuizhou Taibang Biological Products Co Ltd2013-07-31Hypoprothrombinemias
Details
Prothrombinex-VF (CSL Behring)ApprovedCsl Behring LlcAustraliaHemorrhageCsl Behring Llc2014-10-01Hemorrhage
Details
Prothrombin complex concentrate (Sanquin)ApprovedSanquin Plasma Products BvCofactHemorrhageSanquin Plasma Products Bv2007-11-01Hemorrhage
Details
Factor IX complex (Grifols)ApprovedGrifols SaProfilnineUnited StatesHemophilia Bnull1981-07-21Intracranial Hemorrhages; Hemophilia B
Details
Human prothrombin complex (Octapharma)ApprovedOctapharmaOcplex, Octaplex, PronativGermanyHemorrhageOctapharma2003-03-14Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Details
Human prothrombin complex (LFB)ApprovedLfb Biotechnologies SasKANOKADFranceHemorrhageLfb Biotechnologies Sas2008-09-01Hemorrhage
Details
Human prothrombin complex (Tonrol Biopharmaceuticals)ApprovedTonrol Bio-Pharmaceutical Co LtdProthoRAASMainland ChinaHemorrhageShanghai Raas Blood Products Co Ltd1996-01-01Hemophilia B; Hemorrhage
Details
Human prothrombin complex (Guangdong Shuanglin)ApprovedGuangdong Shuanglin Bio-Pharmaceutical Co LtdMainland ChinaHemophilia BGuangdong Shuanglin Bio-Pharmaceutical Co Ltd2023-05-12Hemophilia B
Details
Human prothrombin complex (Shanghai Xinxing)ApprovedMainland ChinaHemorrhageShanghai Xinxing Medicine Co Ltd1997-01-01Hemorrhage
Details
Human prothrombin complex (Sinopharm Shanghai Plasma)ApprovedSinopharm Shanghai Plasma-Derived Biotherapies Co LtdMainland ChinaHemorrhageSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd1997-01-01Hemorrhage
Details
Human prothrombin complex (Boya Bio-Pharmaceutical)ApprovedBoya Bio-Pharmaceutical Group Co LtdMainland ChinaHemorrhageBoya Bio-Pharmaceutical Group Co Ltd2020-12-02Hemophilia B; Hemorrhage
Details
Human prothrombin complex (Guangdong Wellen)ApprovedGuangdong Wellen Pharmaceutical Co LtdMainland ChinaHemorrhageGuangdong Wellen Pharmaceutical Co Ltd2020-10-21Hemophilia B; Hemorrhage
Details
Human prothrombin complex(Hebei Daan Pharmaceutical)ApprovedHebei Daan Pharmaceutical Co LtdMainland ChinaHemorrhageHebei Daan Pharmaceutical Co Ltd2020-01-01Hemophilia B; Hemorrhage
Details
Prothrombin complex concentrat (Taibang Biological Products)ApprovedShandong Taibang Biological Products Co LtdMainland ChinaHemorrhageShandong Taibang Biological Products Co Ltd2014-09-30Hemorrhage; Antithrombin III Deficiency
Details
Human prothrombin complex (Hualan Biological Engineering)ApprovedHualan Genetic Engineering Co LtdMainland ChinaBlood Coagulation Disorders; Factor X DeficiencyHualan Biological Engineering Inc1999-01-01Blood Coagulation Disorders; Hemophilia B; Factor X Deficiency
Details
Human prothrombin complex concentrate (Shanxi Kangbao Biological Products)ApprovedShanxi Kangbao Biological Product Co LtdMainland ChinaHemorrhageShanxi Kangbao Biological Product Co Ltd2019-09-17Hemophilia B; Hemorrhage
Details
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns